Advanced search
Publication Cover
International Journal of Food Properties Volume 26, 2023 - Issue 1
Submit an article Journal homepage
532
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Anti-bladder cancer and COVID-19 potentials of pachymic acid: clinical features and therapeutic targets

Baotong Zhoua Department of Urology Surgery, The Affiliated Hospital of Guilin Medical University, Guilin, PR China;b Department of Nephrology, University of Duisburg-Essen, GermanyView further author information
,
Bojian Liangc Department of Urology Surgery, The Second Affiliated Hospital of Guilin Medical University, Guilin, PR China;d Guangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin, ChinaView further author information
,
Min Chenc Department of Urology Surgery, The Second Affiliated Hospital of Guilin Medical University, Guilin, PR China;d Guangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin, ChinaView further author information
,
Yongbo Tangc Department of Urology Surgery, The Second Affiliated Hospital of Guilin Medical University, Guilin, PR China;d Guangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin, ChinaView further author information
,
Haiwei Huc Department of Urology Surgery, The Second Affiliated Hospital of Guilin Medical University, Guilin, PR China;d Guangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin, ChinaView further author information
,
Qiuhong Chenc Department of Urology Surgery, The Second Affiliated Hospital of Guilin Medical University, Guilin, PR China;d Guangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin, ChinaView further author information
,
Jintao Wenc Department of Urology Surgery, The Second Affiliated Hospital of Guilin Medical University, Guilin, PR China;d Guangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin, ChinaView further author information
,
Zhouliang Wenc Department of Urology Surgery, The Second Affiliated Hospital of Guilin Medical University, Guilin, PR China;d Guangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin, ChinaView further author information
,
Ende Cuic Department of Urology Surgery, The Second Affiliated Hospital of Guilin Medical University, Guilin, PR China;d Guangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin, ChinaView further author information
,
Wei Zhongc Department of Urology Surgery, The Second Affiliated Hospital of Guilin Medical University, Guilin, PR China;d Guangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin, ChinaView further author information
,
Jimin Suc Department of Urology Surgery, The Second Affiliated Hospital of Guilin Medical University, Guilin, PR China;d Guangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin, ChinaView further author information
&
Bo Gec Department of Urology Surgery, The Second Affiliated Hospital of Guilin Medical University, Guilin, PR China;e Guangxi Health Commission Key Laboratory of Glucose and Lipid Metabolism Disorders, The Second Affiliated Hospital of Guilin Medical University, Guilin, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 2679-2691 | Received 10 Apr 2023, Accepted 14 Jul 2023, Published online: 05 Sep 2023

References

  • Sharma, A.; Tiwari, S.; Deb, M. K.; Marty, J. L. Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): A Global Pandemic and Treatment Strategies. Int. J. Antimicrob. Agents. 2020, 56(2), 106054. DOI: 10.1016/j.ijantimicag.2020.106054.
  • Huang, Y. Z.; Kuan, C. C. Vaccination to Reduce Severe COVID-19 and Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis. Eu.R Rev. Med. Pharmacol. Sci. 2022, 26, 1770–1776.
  • Liang, W.; Guan, W.; Chen, R.; Wang, W.; Li, J.; Xu, K.; Li, C.; Ai, Q.; Lu, W.; Liang, H., et al. Cancer Patients in SARS-CoV-2 Infection: A Nationwide Analysis in China. Lancet Oncol. 2020, 21(3), 335–337. DOI: 10.1016/S1470-2045(20)30096-6.
  • Shuman, A. G.; Pentz, R. D. Cancer Research Ethics and COVID-19. Oncologist. 2020, 25(6), 458–459. DOI: 10.1634/theoncologist.2020-0221.
  • Singh, M. K.; Jain, M.; Shyam, H.; Shankar, P.; Singh, V. Associated Pathogenesis of Bladder Cancer and SARS-CoV-2 Infection: A Treatment Strategy. VirusDis. 2021, 32(4), 613–615. DOI: 10.1007/s13337-021-00742-y.
  • Chen, J. Q.; Salas, L. A.; Wiencke, J. K.; Koestler, D. C.; Molinaro, A. M.; Andrew, A. S.; Seigne, J. D.; Karagas, M. R.; Kelsey, K. T.; Christensen, B. C. Immune Profiles and DNA Methylation Alterations Related with Non-Muscle-Invasive Bladder Cancer Outcomes. Clin. Epigenetics. 2022, 14(1), 14. DOI: 10.1186/s13148-022-01234-6.
  • Li, H. Z.; Zheng, R. S.; Du, L. B.; Zhang, S. W.; Zhu, C.; Wei, W. W.; He, J. Bladder Cancer Incidence, Mortality and Temporal Trends in China. Zhonghua Zhong Liu Za Zhi. 2021, 43(3), 293–298. DOI: 10.3760/cma.j.cn112152-20200421-00362.
  • National Cancer Center; Bladder Cancer Expert Committee of National Cancer Quality Control Center. [Quality Control Index for Standardized Diagnosis and Treatment of Bladder Cancer in China (2022 Edition)]. Zhonghua Zhong Liu Za Zhi. 2022, 44(10), 1003–1010. doi:10.3760/cma.j.cn112152-20220803-00531.
  • Li, L.; Zuo, Z. T.; Wang, Y. Z. The Traditional Usages, Chemical Components and Pharmacological Activities of Wolfiporia Cocos: A Review. Am. J. Chin. Med. 2022, 50(2), 389–440. DOI: 10.1142/S0192415X22500161.
  • Wen, H.; Wu, Z.; Hu, H.; Wu, Y.; Yang, G.; Lu, J.; Yang, G.; Guo, G.; Dong, Q. The Anti-Tumor Effect of Pachymic Acid on Osteosarcoma Cells by Inducing PTEN and Caspase 3/7-Dependent Apoptosis. J. Nat. Med. 2018, 72(1), 57–63. DOI: 10.1007/s11418-017-1117-2.
  • Ma, J.; Liu, J.; Lu, C.; Cai, D. Pachymic Acid Induces Apoptosis via Activating ROS-Dependent JNK and ER Stress Pathways in Lung Cancer Cells. Cancer Cell Int. 2015, 15(1), 78. DOI: 10.1186/s12935-015-0230-0.
  • Feng, Z.; Shi, H.; Liang, B.; Ge, T.; Cai, M.; Liu, F.; Huang, K.; Wen, J.; Chen, Q.; Ge, B. Bioinformatics and Experimental Findings Reveal the Therapeutic Actions and Targets of Pachymic Acid Against Cystitis Glandularis. BioFactors. 2021, 47(4), 665–673. DOI: 10.1002/biof.1734.
  • Jeong, J. W.; Lee, W. S.; Go, S. I.; Nagappan, A.; Baek, J. Y.; Lee, J. D.; Lee, S. J.; Park, C.; Kim, G. Y.; Kim, H. J., et al. Pachymic Acid Induces Apoptosis of EJ Bladder Cancer Cells by DR5 Up-Regulation, ROS Generation, Modulation of Bcl-2 and IAP Family Members. Phytother. Res. 2015, 29(10), 1516–1524. DOI: 10.1002/ptr.5402.
  • Wu, Z.; Chen, X.; Ni, W.; Zhou, D.; Chai, S.; Ye, W.; Zhang, Z.; Guo, Y.; Ren, L.; Zeng, Y. The Inhibition of Mpro, the Primary Protease of COVID-19, by Poria Cocos and Its Active Compounds: A Network Pharmacology and Molecular Docking Study. R.S.C. Adv. 2021, 11(20), 11821–11843. DOI: 10.1039/D0RA07035A.
  • Liu, J.; Chen, Y.; Nie, L.; Liang, X.; Huang, W.; Li, R. In Silico Analysis and Preclinical Findings Uncover Potential Targets of Anti-Cervical Carcinoma and COVID-19 in Laminarin, a Promising Nutraceutical. Front Pharmacol. 2022, 13, 955482. DOI: 10.3389/fphar.2022.955482.
  • Yang, L.; Xiong, H.; Li, X.; Li, Y.; Zhou, H.; Lin, X.; Chan, T. F.; Li, R.; Lai, K. P.; Chen, X. Network Pharmacology and Comparative Transcriptome Reveals Biotargets and Mechanisms of Curcumol Treating Lung Adenocarcinoma Patients with COVID-19. Front Nutr. 2022, 9, 870370. DOI: 10.3389/fnut.2022.870370.
  • Yang, L.; Yang, N.; Huang, H.; Yu, J.; Sui, X.; Tao, L.; Gao, Y.; Liu, Z. Bioinformatics Analysis to Identify Intersection Genes, Associated Pathways and Therapeutic Drugs Between COVID-19 and Oral Candidiasis. Comb. Chem. High Throughput Screen. 2023, 26(8), 1533–1546. DOI: 10.2174/1386207325666221007111239.
  • Zheng, W.; Wu, H.; Wang, T.; Zhan, S.; Liu, X. Quercetin for COVID-19 and DENGUE Co-Infection: A Potential Therapeutic Strategy of Targeting Critical Host Signal Pathways Triggered by SARS-CoV-2 and DENV. Brief Bioinform. 2021, 22(6), bbab199. DOI: 10.1093/bib/bbab199.
  • Tang, B.; Zhu, J.; Zhao, Z.; Lu, C.; Liu, S.; Fang, S.; Zheng, L.; Zhang, N.; Chen, M.; Xu, M., et al. Diagnosis and Prognosis Models for Hepatocellular Carcinoma Patient’s Management Based on Tumor Mutation Burden. J. Adv. Res. 2021, 33, 153–165. DOI: 10.1016/j.jare.2021.01.018.
  • McHugh, M. L. The Chi-Square Test of Independence. Biochem. Med. (Zagreb). 2013, 23, 143–149. DOI: 10.11613/BM.2013.018.
  • Cheng, X.; Wang, X.; Nie, K.; Cheng, L.; Zhang, Z.; Hu, Y.; Peng, W. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker. Front. Immunol. 2021, 12, 646523. DOI: 10.3389/fimmu.2021.646523.
  • Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N. S.; Wang, J. T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res. 2003, 13(11), 2498–2504. DOI: 10.1101/gr.1239303.
  • Qin, Q.; Qin, L.; Xie, R.; Peng, S.; Guo, C.; Yang, B. Insight into Biological Targets and Molecular Mechanisms in the Treatment of Arsenic-Related Dermatitis with Vitamin a via Integrated in silico Approach. Front Nutr. 2022, 9, 847320. DOI: 10.3389/fnut.2022.847320.
  • Kim, S.; Chen, J.; Cheng, T.; Gindulyte, A.; He, J.; He, S.; Li, Q.; Shoemaker, B. A.; Thiessen, P. A.; Yu, B., et al. PubChem in 2021: New Data Content and Improved Web Interfaces. Nucleic Acids Res. 2021, 49(D1), 1388–1395. DOI: 10.1093/nar/gkaa971.
  • Seeliger, D.; de Groot, B. L. Ligand Docking and Binding Site Analysis with PyMol and Autodock/Vina. J. Comput. Aided. Mol. Des. 2010, 24(5), 417–422. DOI: 10.1007/s10822-010-9352-6.
  • Yuan, Y.; Jiao, B.; Qu, L.; Yang, D.; Liu, R. The Development of COVID-19 Treatment. Front. Immunol. 2023, 14, 1125246. DOI: 10.3389/fimmu.2023.1125246.
  • de Martel, C.; Georges, D.; Bray, F.; Ferlay, J.; Clifford, G. M. Global Burden of Cancer Attributable to Infections in 2018: A Worldwide Incidence Analysis. Lancet Glob. Health. 2020, 8(2), 180–190. DOI: 10.1016/S2214-109X(19)30488-7.
  • Tran, L.; Xiao, J. F.; Agarwal, N.; Duex, J. E.; Theodorescu, D. Advances in Bladder Cancer Biology and Therapy. Nat. Rev. Cancer. 2021, 21(2), 104–121. DOI: 10.1038/s41568-020-00313-1.
  • Li, T.; Liu, T.; Zhao, Z.; Pan, Y.; Xu, X.; Zhang, Y.; Zhan, S.; Zhou, S.; Zhu, W.; Guo, H., et al. Antifungal Immunity Mediated by C-Type Lectin Receptors May Be a Novel Target in Immunotherapy for Urothelial Bladder Cancer. Front. Immunol. 2022, 13, 911325. DOI: 10.3389/fimmu.2022.911325.
  • Song, D.; Powles, T.; Shi, L.; Zhang, L.; Ingersoll, M. A.; Lu, Y. J. Bladder Cancer, a Unique Model to Understand Cancer Immunity and Develop Immunotherapy Approaches. J. Pathol. 2019, 249(2), 151–165. DOI: 10.1002/path.5306.
  • Martin, A.; Woolbright, B. L.; Umar, S.; Ingersoll, M. A.; Taylor, J. A. Bladder Cancer, Inflammageing and Microbiomes. Nat. Rev. Urol. 2022, 19(8), 495–509. 3rd. DOI: 10.1038/s41585-022-00611-3.
  • Seneviratne, S. L.; Wijerathne, W.; Yasawardene, P.; Somawardana, B. COVID-19 in Cancer Patients. Trans. R. Soc. Trop. Med. Hyg. 2022, 116(9), 767–797. DOI: 10.1093/trstmh/trac015.
  • Su, W.; Han, H. H.; Wang, Y.; Zhang, B.; Zhou, B.; Cheng, Y.; Rumandla, A.; Gurrapu, S.; Chakraborty, G.; Su, J., et al. The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression. Cancer Cell. 2019, 36(2), 139–155. DOI: 10.1016/j.ccell.2019.06.009.
  • Ma, W.; Ou, T.; Cui, X.; Wu, K.; Li, H.; Li, Y.; Peng, G.; Xia, W.; Wu, S. HSP47 Contributes to Angiogenesis by Induction of CCL2 in Bladder Cancer. Cell. Signal. 2021, 85, 110044. DOI: 10.1016/j.cellsig.2021.110044.
  • Conti, I.; Rollins, B. J. CCL2 (Monocyte Chemoattractant Protein-1) and Cancer. Semin. Cancer Biol. 2004, 14(3), 149–154. DOI: 10.1016/j.semcancer.2003.10.009.
  • Pius-Sadowska, E.; Niedźwiedź, A.; Kulig, P.; Baumert, B.; Sobuś, A.; Rogińska, D.; Łuczkowska, K.; Ulańczyk, Z.; Wnęk, S.; Karolak, I., et al. CXCL8, CCL2, and CMV Seropositivity as New Prognostic Factors for a Severe COVID-19 Course. Int. J. Mol. Sci. 2022, 23(19), 11338. DOI: 10.3390/ijms231911338.
  • Isenberg, J. S.; Roberts, D. D. THBS1 (Thrombospondin-1). Atlas Genet Cytogenet. Oncol. Haematol. 2020, 24(8), 291–299. DOI: 10.4267/2042/70774.
  • Nakamura, Y.; Miyata, Y.; Takehara, K.; Asai, A.; Mitsunari, K.; Araki, K.; Matsuo, T.; Ohba, K.; Sakai, H. The Pathological Significance and Prognostic Roles of Thrombospondin-1, and -2, and 4N1K-Peptide in Bladder Cancer. Anticancer. Res. 2019, 39(5), 2317–2324. DOI: 10.21873/anticanres.13348.
  • Xu, G.; Li, J.; Yu, L. MiR-19a-3p Promotes Tumor-Relevant Behaviors in Bladder Urothelial Carcinoma via Targeting THBS1. Comput. Math Methods Med. 2021, 2021, 2710231. DOI: 10.1155/2021/2710231.
  • Hamldar, S.; Kiani, S. J.; Khoshmirsafa, M.; Nahand, J. S.; Mirzaei, H.; Khatami, A.; Kahyesh-Esfandiary, R.; Khanaliha, K.; Tavakoli, A.; Babakhaniyan, K., et al. Expression Profiling of Inflammation-Related Genes Including IFI-16, NOTCH2, CXCL8, THBS1 in COVID-19 Patients. Biologicals. 2022, 80, 27–34. DOI: 10.1016/j.biologicals.2022.09.001.
  • Foley, C. J.; Luo, C.; O’Callaghan, K.; Hinds, P. W.; Covic, L.; Kuliopulos, A. Matrix Metalloprotease-1a Promotes Tumorigenesis and Metastasis. J. Biol. Chem. 2012, 287(29), 24330–24338. DOI: 10.1074/jbc.M112.356303.
  • Du, X.; Lin, B. C.; Wang, Q. R.; Li, H.; Ingalla, E.; Tien, J.; Rooney, I.; Ashkenazi, A.; Penuel, E.; Qing, J. MMP-1 and Pro-MMP-10 as Potential Urinary Pharmacodynamic Biomarkers of FGFR3-Targeted Therapy in Patients with Bladder Cancer. Clin. Cancer Res. 2014, 20(24), 6324–6335. DOI: 10.1158/1078-0432.CCR-13-3336.
  • Syed, F.; Li, W.; Relich, R. F.; Russell, P. M.; Zhang, S.; Zimmerman, M. K.; Yu, Q. Excessive Matrix Metalloproteinase-1 and Hyperactivation of Endothelial Cells Occurred in COVID-19 Patients and Were Associated with the Severity of COVID-19. J. Infect. Dis. 2021, 224(1), 60–69. DOI: 10.1093/infdis/jiab167.
  • Yang, T.; Tian, S.; Wang, Y.; Ji, J.; Zhao, J. Antitumor Activity of Pachymic Acid in Cervical Cancer Through Inducing Endoplasmic Reticulum Stress, Mitochondrial Dysfunction, and Activating the AMPK Pathway. Environ. Toxico. 2022, 37(9), 2121–2132. DOI: 10.1002/tox.23555.
  • Gui, Y.; Sun, L.; Liu, R.; Luo, J. Pachymic Acid Inhibits Inflammation and Cell Apoptosis in Lipopolysaccharide (LPS)-Induced Rat Model with Pneumonia by Regulating NF-Κb and MAPK Pathways. Allergol. Immunopathol. 2021, 49(5), 87–93. DOI: 10.15586/aei.v49i5.468.
  • Lee, Y. H.; Lee, N. H.; Bhattarai, G.; Kim, G. E.; Lee, I. K.; Yun, B. S.; Hwang, P. H.; Yi, H. K. Anti-Inflammatory Effect of Pachymic Acid Promotes Odontoblastic Differentiation via HO-1 in Dental Pulp Cells. Oral Dis. 2013, 19(2), 193–199. DOI: 10.1111/j.1601-0825.2012.01970.x.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.